Compounds > 2-piperidone
Page last updated: 2024-08-21

2-piperidone and Prostatic Neoplasms

2-piperidone has been researched along with Prostatic Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, SW; Kim, AR; Kim, DI; Lee, JY; Shin, SW; Um, SH1
Abnous, K; Danesh, NM; Ramezani, M; Sarreshtehdar Emrani, A; Tabrizian, K; Taghdisi, SM; Zandkarimi, M1
Pfeffer, LM; Sims, M; Yang, CH; Yue, J1
Ahn, SC; Chang, JH; Cho, HJ; Kim, KY; Kim, YJ; Kong, EH; Yu, SN1
Chandra, D; Choy, G; Tang, DG1
Crissman, JD; Honn, KV; Johnson, CR; Joshi, B; Krajewski, S; Li, L; Marnett, LJ; Porter, AT; Reed, JC; Tang, DG; Timar, J; Zhu, Z1
Ben-Josef, E; Joshi, B; Li, L; Porter, AT; Taffe, BG; Tang, DG; Taylor, JD; Tian, H; Wahl, S; Zhu, Z1

Other Studies

7 other study(ies) available for 2-piperidone and Prostatic Neoplasms

ArticleYear
A light-driven anti-cancer dual-therapeutic cassette enhances solid tumour regression.
    Advanced healthcare materials, 2013, Volume: 2, Issue:9

    Topics: Animals; Antibiotics, Antineoplastic; Benzeneacetamides; Cell Line; Cell Survival; DNA; Doxorubicin; Drug Design; Gold; Humans; Hyperthermia, Induced; Light; Male; Metal Nanoparticles; Mice; Mice, Nude; Nanoparticles; Piperidones; Prostatic Neoplasms; RNA; Transplantation, Heterologous

2013
Targeted delivery of Epirubicin to cancer cells by PEGylated A10 aptamer.
    Journal of drug targeting, 2013, Volume: 21, Issue:8

    Topics: Antigens, Neoplasm; Antineoplastic Agents; Aptamers, Nucleotide; Benzeneacetamides; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Epirubicin; Humans; Male; Piperidones; Polyethylene Glycols; Prostatic Neoplasms

2013
The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo.
    PloS one, 2013, Volume: 8, Issue:8

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzylidene Compounds; Cell Line, Tumor; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; MicroRNAs; Piperidones; Prostatic Neoplasms; RNA Interference; Signal Transduction; Transcription Factor RelA; Xenograft Model Antitumor Assays

2013
Piplartine induces caspase-mediated apoptosis in PC-3 human prostate cancer cells.
    Oncology reports, 2008, Volume: 20, Issue:4

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; CDC2 Protein Kinase; Cell Division; Cell Line, Tumor; Cyclin B; Cyclin B1; Cyclin-Dependent Kinases; DNA Fragmentation; G2 Phase; Humans; Male; Piperidones; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2

2008
Cytosolic accumulation of HSP60 during apoptosis with or without apparent mitochondrial release: evidence that its pro-apoptotic or pro-survival functions involve differential interactions with caspase-3.
    The Journal of biological chemistry, 2007, Oct-26, Volume: 282, Issue:43

    Topics: Apoptosis; Breast Neoplasms; Caspase 3; Cell Line, Transformed; Cell Line, Tumor; Cells, Cultured; Chaperonin 60; Cytosol; Down-Regulation; Enzyme Activation; Female; Fibroblasts; Fluorescent Dyes; HCT116 Cells; Humans; Hydroxamic Acids; Indoles; Male; Mitochondria; Piperidones; Prostatic Neoplasms; Recombinant Proteins; RNA, Messenger; RNA, Small Interfering; Subcellular Fractions; Time Factors; Transfection

2007
BMD188, A novel hydroxamic acid compound, demonstrates potent anti-prostate cancer effects in vitro and in vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteases.
    Pathology oncology research : POR, 1998, Volume: 4, Issue:3

    Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Endopeptidases; Enzyme Activation; Humans; Hydroxamic Acids; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, SCID; Mitochondria; Neoplasm Proteins; Neoplasm Transplantation; Piperidones; Prostatic Neoplasms; Reactive Oxygen Species; Serine Proteinase Inhibitors

1998
Apoptosis induction by a novel anti-prostate cancer compound, BMD188 (a fatty acid-containing hydroxamic acid), requires the mitochondrial respiratory chain.
    Cancer research, 1999, Sep-01, Volume: 59, Issue:17

    Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Electron Transport; Humans; Hydroxamic Acids; Male; Membrane Potentials; Mitochondria; Piperidones; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Reactive Oxygen Species; Staurosporine; Tumor Cells, Cultured

1999